That type of use of the MRX technology would be a huge step forward for everyone. The problem is the gap between what could happen and what actually does is a huge black hole. Look at recent announcements. Upham hired supposedly to find a partner because of her success with commercializing her diabetes discovery. A year later not a word about what she did or if she is even still engaged. Last year they announced hiring an FDA approval process expert to guide them through the process. Last thing ever mentioned. MDA says human studies could begin within 5 years. No clue from the company if that is the new timeframe for expectations. Big headlines about Falk and the fork in the road. But somehow must be stuck in traffic and not heard from since. November p/r: "The Company plans to initiate construction of a human-size clinical MRX machine in 2015". So has construction begun? Why not say "will initiate"? Or when it will be completed?
For those wondering why the share price is going in the wrong direction, look no further than the black hole of confusion regarding how long (if ever) it will take to finally prove this technology even works and how much it will cost to take it to a place where it is attractive to someone in the commercial healthcare industry. 5+ years company still has not disclosed this type of information. No wonder no takers for licensing, partnering or even paying what the stock was worth 5 years ago.
News 
Market Data 
Discover 
